UK Markets open in 7 hrs 48 mins

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
5.85-0.05 (-0.85%)
At close: 2:57PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 516.08M
Enterprise value 32.43M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)82.89
Price/book (mrq)136.05
Enterprise value/revenue 312.51
Enterprise value/EBITDA 7-0.76

Trading information

Stock price history

Beta (5Y monthly) 1.52
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 315.27
52-week low 32.96
50-day moving average 35.82
200-day moving average 37.19

Share statistics

Avg vol (3-month) 32.42M
Avg vol (10-day) 3831.14k
Shares outstanding 5274.89M
Implied shares outstanding 6N/A
Float 203.36M
% held by insiders 128.51%
% held by institutions 138.45%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2021
Most-recent quarter (mrq)31 Mar 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,656.19%

Management effectiveness

Return on assets (ttm)-23.25%
Return on equity (ttm)-33.39%

Income statement

Revenue (ttm)194k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-3.19M
EBITDA -3.19M
Net income avi to common (ttm)-2.67M
Diluted EPS (ttm)-1.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.59M
Total cash per share (mrq)0.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)20.34
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-2.93M
Levered free cash flow (ttm)-2.27M